vocal biomarker
The tool is also able to check the lung condition of COVID-19 patients.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The tool was "100% accurate" when spotting cases among asymptomatic individuals, the researchers wrote, and could be deployed as a low-cost prescreener to support diagnostic testing efforts.
Also: Vocalis Health and Mayo Clinic seek new pulmonary hypertension biomarkers; Sensyne Health and Microsoft's strategic partnership focuses on clinical AI co-development.
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.
The deal joins each company's voice sample datasets to improve R&D, and helps Sonde collect more data across platforms.
New agreements with five different tech companies and research organizations aim to expand and flesh out the digital therapeutics maker's product pipeline.